Malignant Melanoma clinical trials

Explore recruiting malignant melanoma clinical trials.

Recruiting malignant melanoma studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Malignant Melanoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A prospective randomized international multicenter study to compare Short versus Long Adjuvant immunotherapy after radical surgery of stage IIb-c, III and IV cutaneous malignant Melanoma (Grand SLAM)

Finland, Norway, Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

Research on two creams (Monobenzon / Imiquimod) together with the standard treatment for advanced or metastatic melanoma (ImMI).

Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

BEFAST STUDY: [68Ga]Ga-FAPI total body PET/CT for Better and Faster imaging in cancer [68Ga]Ga-FAPI PET/CT for response evaluation during immune checkpoint inhibitor therapy in malignant melanoma

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

INtra-tumor miCro dosIng in PatIents with advanced malignant mElanoma receiving aNti-PD1 Therapy. A pilot study.

Belgium

Human Pharmacology (Phase I)- Other EU CTIS Study details

A phase Ib/II randomized double-blind placebo controlled trial evaluating the effect of nivolumab for patients with in-transit melanoma metastases treated with isolated limb perfusion

Sweden, Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

SWE-NEO: Swedish NeoAdjuvant Trial Comparing anti-PD-1 Monotherapy to Combined anti-CTLA-4/anti-PD-1 blockade in Resectable Stage III Melanoma

Sweden

Therapeutic confirmatory (Phase III) EU CTIS Study details

Malignant Melanoma trials by city

Malignant Melanoma in Toronto Malignant Melanoma in Vancouver Malignant Melanoma in Montreal Malignant Melanoma in Calgary Malignant Melanoma in Edmonton Malignant Melanoma in Ottawa Malignant Melanoma in Winnipeg Malignant Melanoma in Quebec City Malignant Melanoma in Hamilton Malignant Melanoma in Kitchener Malignant Melanoma in London Malignant Melanoma in Halifax Malignant Melanoma in New York Malignant Melanoma in Los Angeles Malignant Melanoma in Chicago Malignant Melanoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease